Physician profile
Michael Zammit
NPI 1841251188
$3,942.50
in general payments reported to CMS, 2019-2025
19 companies · $902 in 2025
The $902 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $355 · 2020: $317 · 2021: $476 · 2022: $459 · 2023: $699 · 2024: $734 · 2025: $902.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,334.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $645.14 | 2021-2023 | Ellipsys Vascular Access System, Hawkone |
| Shockwave Medical, INC | $518.63 | 2019-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Stryker Corporation | $479.62 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Flowtriever |
| Philips North America LLC | $456.21 | 2019-2024 | (6536) Phoenix |
| Inari Medical, INC. | $440.58 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Endologix LLC | $242.14 | 2025 | Torus Stent Graft System, Endocross Device |
| Lemaitre Vascular, INC. | $231.56 | 2019-2025 | Artegraft Vascular Graft, Anastoclip Gc 8cm (Medium), Hydro Lemaitre Valvulotome |
| Medtronic Vascular, INC. | $183.40 | 2019-2020 | |
| Abbott Laboratories | $165.23 | 2020-2024 | Jeti All In One Non-Sterile Kit |
| Janssen Pharmaceuticals, INC | $131.51 | 2019-2021 | |
| Cook Medical LLC | $114.50 | 2024 | Rosen, Zilver Ptx, Icast Covered Stent System, 6mmx22mmx120cm |
| W. L. Gore & Associates, INC. | $71.35 | 2023-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Viabahn Endoprosthesis |
| Boston Scientific Corporation | $69.07 | 2020 | |
| Organogenesis INC. | $55.31 | 2024 | |
| Cardiovascular Systems INC. | $42.26 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $36.61 | 2020-2022 | |
| Tactile Systems Technology INC | $27.45 | 2024 | Flexitouch Plus, Entre Plus |
| Merck Sharp & Dohme LLC | $16.73 | 2023 | Bridion |
| Covidien LP | $15.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Zammit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.